Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Merck Invests Over €300M in Advanced Life Science Research Center in Germany
Merck is investing over 300 million in a new research center at its global headquarters in Darmstadt, Germany This Advanced Research Center will focus on developing solutions
£400 Million Investment by Almac Group to Boost Manufacturing and Peptide Production
The Almac Group has introduced two stateoftheart facilities at its Craigavon headquarters in Northern Ireland, pushing its global expansion investment to over 400 million $500 million
Novartis Invests $256 Million to Expand Singapore Biopharma Plant
In a significant move to enhance its global production capabilities, Novartis has announced a commitment of $256 million to expand its biopharma plant in Singapore
Pharmascience Expands CDMO Services with $120M Commercial Unit Investment in Canada
Pharmascience, Canadas leading pharmaceutical company, announces an expansion of its sterile injectable manufacturing facility at the Candiac site
Simtra BioPharma Invests $250 Million in Bloomington Sterile Fill/Finish Site
Simtra BioPharma Solutions, recently acquired by Advent International and Warburg Pincus, is expanding its sterile fillfinish manufacturing campus in Bloomington, Indiana
The Ground breaking Commencement of Lek's $400M Biopharmaceutical Production Center Project in Lendava
Initiation of construction for Leks advanced biopharmaceutical production center in Lendava is underway The construction will occur on Leks existing site in Lendava and involves three planned facilities
BioNTech's $150M Investment Propels Rwanda toward mRNA Vaccine Manufacturing Hub
BioNTech SE reaches a significant milestone with the inauguration of its mRNA vaccine manufacturing site in Kigali, Rwanda The site includes the establishment of the first manufacturing
Novo Nordisk Initiates Groundbreaking 16 Billion Danish Kroner Investment for State-of-the-Art Expansion in France
The expansion is geared towards enhancing production capabilities for the current and future portfolio focused on serious chronic diseases
Novo Nordisk Invests Over 42 Billion Danish Kroner in Expanding Manufacturing Facilities in Kalundborg
Novo Nordisk plans to invest more than 42 billion Danish kroner starting in 2023 The investment is focused on expanding existing manufacturing facilities in Kalundborg, Denmark
Gerresheimer Initiates Groundbreaking for New Facility in Querétaro, Supported by a $109.28 Million (100 Million Euro) Investment
The expansion focuses on increasing production capacities for readytofill RTF syringes for the North American market
